King Wealth

SEC CIK: 0001568235
Latest filing: Aug 5, 2026

SEC filings (opens in a new tab)

ACAD holding history

Acadia Pharmaceuticals Inc in every 13F filed by King Wealth, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ACAD overview All 13F holders of ACAD Full Q2 2026 holdings

Shares (Q2 2021): 0; Sold out in Q2 2021
Value: $0
% of portfolio: 0.0%
Quarters held: 1; Since Q1 2021

Holdings of ACAD by King Wealth, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2021	0	$0	0.0%	−8,000−100.0%	Sold out	Holders
Q1 2021	8,000	$206.0K	<0.1%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.